Related Experiment Video
Updated: May 25, 2026
10:50
Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
Arteriogenesis versus angiogenesis in peripheral artery disease
Kerstin Troidl1, Wolfgang Schaper
1Division of Arteriogenesis Research, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Diabetes/Metabolism Research and Reviews
|January 25, 2012
Summary
Therapeutic stimulation of collateral vessel growth, including arteriogenesis and angiogenesis, aids recovery from blocked arteries. This study explores regulatory mechanisms and proposes how vessel size is optimized for efficient blood flow.
Area of Science:
- Cardiovascular Biology
- Vascular Medicine
- Regenerative Medicine
Background:
- Occluded arteries trigger compensatory vessel growth in adults.
- Arteriogenesis and angiogenesis are distinct forms of vessel growth.
- Understanding these processes is crucial for therapeutic interventions.
Purpose of the Study:
- To summarize key differences between arteriogenesis and angiogenesis.
- To present evidence supporting therapeutic stimulation of collateral growth.
- To outline regulatory mechanisms of collateral vessel development.
Main Methods:
- Literature review and synthesis of current knowledge.
- Analysis of regulatory pathways in collateral vessel formation.
- Discussion of the role of nitric oxide in arteriogenesis.
- Proposal of a mechanism for differential collateral growth.
Main Results:
- Distinct characteristics of arteriogenesis and angiogenesis identified.
- Evidence supports the therapeutic potential of stimulating collateral growth.
- Key regulatory mechanisms, including nitric oxide signaling, are discussed.
- A proposed mechanism explains the selective enlargement of larger collaterals.
Conclusions:
- Stimulating collateral vessel growth offers therapeutic promise for arterial occlusion.
- Nitric oxide plays a significant role in arteriogenesis.
- A regulatory mechanism ensures efficient adaptation of collateral vessel size.
Related Concept Videos
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...